Abstract
Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have